FindTrial
Sign In

Proteinuria and its relation with severity of neuropathy in Type II diabetes

Albuminuria as a marker of severity of neuropathy of type 2 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/032307
Enrollment
86
Registered
2021-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications Health Condition 2: E114- Type 2 diabetes mellitus with neurological complications

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Known Type II diabetic 2) Newly detected Type II diabetic 3) Age more than 18 years

Exclusion criteria

Exclusion criteria: 1) Gestational Diabetes 2) Known Type I diabetic 3) Patients who are unable to give an informed consent 4) Patients with UTI 5) Patients who are known to have kidney disease 6) Patients with diagnosed malignancy 7) Patients with Spinal Injury 8) Patient with intervertebral disc prolapse 9) Patients who are known to have hypothyroidism 10) Alcohol intake of more than 14 units per week.

Design outcomes

Primary

MeasureTime frame
1) To estimate levels of albuminuria in patients with type 2 diabetes 2) To assess the severity of diabetic neuropathy using presenting symptoms and physical examination Timepoint: Immediate—

Secondary

MeasureTime frame
3) To correlate the levels of urinary albumin and the severity of peripheral neuropathyTimepoint: Immediate—

Countries

India

Contacts

Public ContactCol R Arunachalam

Father Muller Medical College

arunachalam14759@yahoo.com9481846382

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026